Literature DB >> 8692976

Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase.

M Shimada1, S Ishibashi, T Inaba, H Yagyu, K Harada, J I Osuga, K Ohashi, Y Yazaki, N Yamada.   

Abstract

Lipoprotein lipase (LPL) is a key enzyme in the hydrolysis of triglyceride-rich lipoproteins. Conflicting results have been reported concerning its role in atherogenesis. To determine the effects of the overexpressed LPL on diet-induced atherosclerosis, we have generated low density lipoprotein receptor (LDLR) knockout mice that overexpressed human LPL transgene (LPL/LDLRKO) and compared their plasma lipoproteins and atherosclerosis with those in nonexpressing LDLR-knockout mice (LDLRKO). On a normal chow diet, LPL/LDLRKO mice showed marked suppression of mean plasma triglyceride levels (32 versus 236 mg/dl) and modest decrease in mean cholesterol levels (300 versus 386 mg/dl) as compared with LDLRKO mice. Larger lipoprotein particles of intermediate density lipoprotein (IDL)/LDL were selectively reduced in LPL/LDLRKO mice. On an atherogenic diet, both mice exhibited severe hypercholesterolemia. But, mean plasma cholesterol levels in LPL/ LDLRKO mice were still suppressed as compared with that in LDLRKO mice (1357 versus 2187 mg/dl). Marked reduction in a larger subfraction of IDL/LDL, which conceivably corresponds to remnant lipoproteins, was observed in the LPL/LDLRKO mice. LDLRKO mice developed severe fatty streak lesions in the aortic sinus after feeding with the atherogenic diet for 8 weeks. In contrast, mean lesion area in the LPL/LDLRKO mice was 18-fold smaller than that in LDLRKO mice. We suggest that the altered lipoprotein profile, in particular the reduced level of remnant lipoproteins, is mainly responsible for the protection by LPL against atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692976      PMCID: PMC38967          DOI: 10.1073/pnas.93.14.7242

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Atherogenic lipoproteins and coronary artery disease: concepts derived from recent advances in cellular and molecular biology.

Authors:  R W Mahley
Journal:  Circulation       Date:  1985-11       Impact factor: 29.690

Review 2.  Fibric acids: effects on lipids and lipoprotein metabolism.

Authors:  S M Grundy; G L Vega
Journal:  Am J Med       Date:  1987-11-27       Impact factor: 4.965

3.  Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells.

Authors:  M Aviram; E L Bierman; A Chait
Journal:  J Biol Chem       Date:  1988-10-25       Impact factor: 5.157

4.  Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men.

Authors:  R M Krauss; F T Lindgren; P T Williams; S F Kelsey; J Brensike; K Vranizan; K M Detre; R I Levy
Journal:  Lancet       Date:  1987-07-11       Impact factor: 79.321

5.  Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey.

Authors:  I J Goldberg; N A Le; H N Ginsberg; R M Krauss; F T Lindgren
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

6.  Quantitative assessment of atherosclerotic lesions in mice.

Authors:  B Paigen; A Morrow; P A Holmes; D Mitchell; R A Williams
Journal:  Atherosclerosis       Date:  1987-12       Impact factor: 5.162

7.  Variation in susceptibility to atherosclerosis among inbred strains of mice.

Authors:  B Paigen; A Morrow; C Brandon; D Mitchell; P Holmes
Journal:  Atherosclerosis       Date:  1985-10       Impact factor: 5.162

8.  Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein.

Authors:  E Sehayek; U Lewin-Velvert; T Chajek-Shaul; S Eisenberg
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

9.  Apolipoprotein E and lipoprotein lipase secreted from human monocyte-derived macrophages modulate very low density lipoprotein uptake.

Authors:  S Ishibashi; N Yamada; H Shimano; N Mori; H Mokuno; T Gotohda; M Kawakami; T Murase; F Takaku
Journal:  J Biol Chem       Date:  1990-02-25       Impact factor: 5.157

Review 10.  Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases.

Authors:  R H Eckel
Journal:  N Engl J Med       Date:  1989-04-20       Impact factor: 91.245

View more
  25 in total

Review 1.  Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases.

Authors:  Werner J Geldenhuys; Li Lin; Altaf S Darvesh; Prabodh Sadana
Journal:  Drug Discov Today       Date:  2016-10-19       Impact factor: 7.851

Review 2.  Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics.

Authors:  Amit V Khera; Daniel J Rader
Journal:  Trends Cardiovasc Med       Date:  2009-08       Impact factor: 6.677

3.  Daily supplementation with fresh pomegranate juice increases paraoxonase 1 expression and activity in mice fed a high-fat diet.

Authors:  D Estrada-Luna; E Martínez-Hinojosa; J C Cancino-Diaz; H Belefant-Miller; G López-Rodríguez; G Betanzos-Cabrera
Journal:  Eur J Nutr       Date:  2017-02-27       Impact factor: 5.614

4.  Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity.

Authors:  Manabu Takahashi; Hiroaki Yagyu; Fumiko Tazoe; Shuichi Nagashima; Taichi Ohshiro; Kenta Okada; Jun-ichi Osuga; Ira J Goldberg; Shun Ishibashi
Journal:  J Lipid Res       Date:  2013-02-03       Impact factor: 5.922

5.  Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice.

Authors:  Chuchun L Chang; Claudia Torrejon; Un Ju Jung; Kristin Graf; Richard J Deckelbaum
Journal:  Atherosclerosis       Date:  2014-04-03       Impact factor: 5.162

6.  The combined role of P- and E-selectins in atherosclerosis.

Authors:  Z M Dong; S M Chapman; A A Brown; P S Frenette; R O Hynes; D D Wagner
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

Review 7.  Murine mentors: transgenic and knockout models of surgical disease.

Authors:  J M Arbeit; R Hirose
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

8.  Endothelial lipase is a major determinant of HDL level.

Authors:  Tatsuro Ishida; Sungshin Choi; Ramendra K Kundu; Ken-Ichi Hirata; Edward M Rubin; Allen D Cooper; Thomas Quertermous
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 9.  Inflammation associated with the postprandial lipolysis of triglyceride-rich lipoproteins by lipoprotein lipase.

Authors:  Laura J Higgins; John C Rutledge
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

Review 10.  Endothelial lipase and cholesterol metabolism.

Authors:  Mehmet Cilingiroglu; Christie Ballantyne
Journal:  Curr Atheroscler Rep       Date:  2004-03       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.